JAYDE BARNES: Open Payments
NPI 1023618659 · AMMON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 13 payments from 8 companies in 2025. Trend: 2023 $577 · 2024 $920 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 3 | $80 |
| ABBVIE INC. | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: SUBLOCADE, VRAYLAR, FANAPT, CAPLYTA, APTIMA, ABILIFY ASIMTUFII, ARISTADA, Auvelity.
Industry payments across ID — which companies pay providers there.
